Physician profile
Fahad Hawk
NPI 1689170219
$31,267.22
in general payments reported to CMS, 2019-2025
12 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $637 · 2023: $1,002 · 2024: $1,500 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $24K · Food and Beverage: $4,817 · Travel and Lodging: $1,285 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $24,196.00 |
| Food and Beverage | $4,816.56 |
| Travel and Lodging | $1,285.38 |
| Education | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,091.14 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Ffrangio |
| Abbott Laboratories | $11,146.23 | 2023-2025 | Mitraclip, Cardiomems, Diamondback Coronary |
| Boston Scientific Corporation | $933.76 | 2022-2025 | General - Therapies, Watchman Flx |
| Edwards Lifesciences Corporation | $550.42 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $528.23 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $489.07 | 2025 | |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Cardiovascular Systems INC. | $125.50 | 2022 | |
| Biotronik INC. | $100.06 | 2022-2025 | Solia |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $67.80 | 2022 | |
| Kestra Medical Technology Services, INC. | $23.50 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahad Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.